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g/10.1016Abstract Insulin dependent diabetes mellitus (IDDM) is a global disease with high economic and
social burden. A potential cure for type 1 diabetes is pancreatic islet transplantation. Despite recent
improvements, islets are faced with various types of stress related to the isolation and transplanta-
tion procedure. Oxidative stress plays an essential role in cell damage during islet isolation and
transplantation procedures. In this article, we hypothesise that a combination of cerium and yttrium
oxide nanoparticles, as a power antioxidant with free-radical-scavenging activity, because of
enhancing the survival or viability of cells in vitro can improve islet transplantation. No doubt,
administration of this improvement can be used in diabetes treatment.
ª 2012 Tehran University of Medical Sciences. Published by Elsevier Ltd.Open access under CC BY-NC-ND license. Introduction
Insulin dependent diabetes mellitus (IDDM)which is character-
ised by hyperglycaemia has become an important disorder with
major costs and complications worldwide. As shown in Fig. 1,
IDDM is the outcome of autoimmune process that is followed
by pancreatic beta cell destruction [1]. Patients with IDDMneed
to follow persistent insulin therapy that improves primary
symptoms of diabetes but this treatment cannot be effective(M. Abdollahi).
niversity of Medical Sciences. Pub
h/
/j.jmhi.2012.03.005on secondary complications, that is, microangiopathy, macro-
angiopathy and neuropathy, although can delay the onset of
these complications [2]. Thus, islet transplantation as a promis-
ing treatment for type 1 diabetes has been widely considered.
Despite the progress made in this case, islet transplantation
is faced with different types of stress related to the isolation
and transplantation procedure which lead to excessive oxida-
tive stress and low viability and function of islets. Oxidative
stress plays an essential role in the damage of islet duringlished by Elsevier Ltd. Open access under CC BY-NC-ND license. 
Figure 1 Oxidative stress and pancreatic ß-cell dysfunction. The islets are particularly at risk for chronic oxidative stress. ROM:
Reactive Oxygen Molecules; AGE: Advanced Glycation End-product.
Through a mechanism-based approach, nanoparticles 5isolation and transplantation procedures [1]. Notably, islets for
inherently low antioxidant capacity are vulnerable to oxida-
tive-induced damage [3].
In recent years, many studies have been carried out to opti-
mise islet transplantation procedures. Antioxidants such as
vitamin supplements, trace elements and drugs have been
widely used to improve the function of isolated islets [3,4]. Re-
cent studies reported that a new drug named IMOD with
antioxidative capacities improves viability and insulin secre-
tion of isolated islet [5]. Interestingly, a recent study proved
that phosphodiesterase inhibitors that ﬁghting against oxida-
tive stress can facilitate conditions of islet transplantation [6].
In an animal model of diabetes, nanocerium was found
effective in the reduction of diabetes complications by its
strong antioxidative effects [7]. Yttrium oxide is noteworthy
for the free energy of oxide formation from elemental yttrium
that showed potential scavenger behaviour similar to cerium.
Both cerium and yttrium oxide nanoparticles are neuroprotec-
tive because of their antioxidant effects [8].
Hypothesis
We propose that a combination of cerium and yttrium oxide
nanoparticles can act as a power antioxidant with higher
free-radical-scavenging potential. This combination can en-
hance the survival or viability of cells in vitro and improve islet
transplantation. The idea of using a combination of cerium
and yttrium oxide nanoparticles in the direction of improving
islet function will remain a function of islets after isolation
from the pancreas before the procedure of transplantation.
Obviously, this combination will be a useful therapeutic strat-
egy in the future for diabetes.
Evaluation of hypothesis
The following procedures are recommended to test the
hypothesis:
1. Isolation of islets from animal and culturing in media.
2. Dose optimisation by pretreating islets with various con-
centrations of nanoparticles.
3. Dividing of islets into different pretreatment groups in the
presence of oxidative stress-inducing agents.4. Testing islets for secretion of insulin in the presence of var-
ious concentrations of glucose. This test evaluates insulin
secretory function of the islets.
5. Testing of islets for viability/survival, reactive oxygen mole-
cules, rate of energy and evaluation of cell death (apoptosis).Discussion
Hereby, a novel strategy to improve islet transplantation is
proposed. Cerium nanoparticles are known as free-radical
scavengers [9] having oxygen vacancies for dual oxidation
states that is created by loss of oxygen and the reduction of
Ce+4 to Ce+3 [10]. These nanoparticles have several advanta-
ges over other antioxidants:
1. Cerium oxide nanoparticles act as catalysts to mimetic
superoxide dismutase activity [11].
2. Antioxidant activity of these nanoparticles is mediated at
oxygen vacancies on the surface. It seems that, one cerium
oxide nanoparticle offers many sites for catalysis, despite
the fact that pharmacological agents or enzymes have only
one active site per molecule.
3. These nanoparticles remain resident and active in a living
cell and active for an extended period of time [12].
Nanoparticles of yttrium oxide have also shown potential
scavenger behaviour similar to ceria. Therefore, nanoparticles
of cerium and yttrium in line of antioxidant properties [8] may
act synergistic or additive to protect cells against oxidative stress.
Surely, the safety and effectiveness of this treatment should
ﬁrst be investigated in animal and in vitro models.
Conclusion
Through a mechanism-based approach, a combination of cer-
ium and yttrium oxide nanoparticles possibly can improve islet
transplantation.
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6 A. Hosseini, M. AbdollahiOverview Box
What do we already know about the subject?
1. Diabetes is an important disorder with major costs
and complications worldwide.
2. Patients with IDDM need to follow persistent insu-
lin therapy but it cannot be effective on all of diabetes
complications.
3. A potential cure for type 1 diabetes is pancreatic islet
transplantation.
4. Oxidative stress during isolation of islets reduces
survival and functionality of islets.
What does your proposed theory add to the current
knowledge available, and what beneﬁt does it have?
This hypothesis introduces a new mixture that might
be able to improve islet survival and functionality for
the purpose of islet transplantation.
Among numerous available studies, what special further
study is proposed for testing the idea?
The hypothesis can be tested ﬁrst in isolated rat islets.
Dose optimisation and safety for the mixture of nanoceri-
um and nanoyttrium would be performed.References
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